{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:58:59Z","timestamp":1792839539117,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009750","name":"University of Rochester Medical Center","doi-asserted-by":"publisher","award":["STUDY00003839"],"award-info":[{"award-number":["STUDY00003839"]}],"id":[{"id":"10.13039\/100009750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.modpat.2025.100815","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T19:33:54Z","timestamp":1749843234000},"page":"100815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Characterization of Cholangiocarcinomas With Tubulocystic Morphology Associated With Biliary Adenofibroma or Biliary Adenofibroma-Like Lesions"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5052-0632","authenticated-orcid":false,"given":"Xiaoyan","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Agostini-Vulaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.modpat.2025.100815_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.modpat.2025.100815_bib2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100815_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.32074\/1591-951X-251","article-title":"Benign biliary neoplasms and biliary tumor precursors","volume":"113","author":"Sarcognato","year":"2021","journal-title":"Pathologica"},{"key":"10.1016\/j.modpat.2025.100815_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/805973","article-title":"What are the precursor and early lesions of peripheral intrahepatic cholangiocarcinoma?","volume":"2014","author":"Nakanuma","year":"2014","journal-title":"Int J Hepatol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100815_bib5","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ar.20710","article-title":"Embryology of extra- and intrahepatic bile ducts, the ductal plate","volume":"291","author":"Roskams","year":"2008","journal-title":"Anat Rec (Hoboken)"},{"key":"10.1016\/j.modpat.2025.100815_bib6","series-title":"Digestive System Tumours","author":"Board","year":"2019"},{"issue":"4","key":"10.1016\/j.modpat.2025.100815_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.5009\/gnl210174","article-title":"Genetic, clinicopathological, and radiological features of intrahepatic cholangiocarcinoma with ductal plate malformation pattern","volume":"16","author":"Chung","year":"2022","journal-title":"Gut Liver"},{"issue":"4","key":"10.1016\/j.modpat.2025.100815_bib8","doi-asserted-by":"crossref","first-page":"652","DOI":"10.21037\/jgo.2018.08.18","article-title":"Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets","volume":"10","author":"Weinberg","year":"2019","journal-title":"J Gastrointest Oncol"},{"issue":"11","key":"10.1016\/j.modpat.2025.100815_bib9","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1097\/PAS.0b013e31826e0249","article-title":"Intrahepatic cholangiocarcinoma with predominant \"ductal plate malformation\" pattern: a new subtype","volume":"36","author":"Nakanuma","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100815_bib10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3350\/cmh.2014.20.2.214","article-title":"Intrahepatic cholangiocarcinoma with predominant ductal plate malformation pattern","volume":"20","author":"Choe","year":"2014","journal-title":"Clin Mol Hepatol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100815_bib11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/PAS.0000000000001201","article-title":"Cholangiolocellular carcinoma with \"ductal plate malformation\" pattern may be characterized by ARID1A genetic alterations","volume":"43","author":"Sasaki","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100815_bib12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00000478-199302000-00010","article-title":"Biliary adenofibroma. A heretofore unrecognized benign biliary tumor of the liver","volume":"17","author":"Tsui","year":"1993","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100815_bib13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00000478-200305000-00014","article-title":"Biliary adenofibroma: a rare neoplasm of bile duct origin with an indolent behavior","volume":"27","author":"Varnholt","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2025.100815_bib14","article-title":"Biliary adenofibroma of the liver: report of a case and review of the literature","volume":"2010","author":"Gurrera","year":"2010","journal-title":"Patholog Res Int"},{"issue":"4","key":"10.1016\/j.modpat.2025.100815_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/PAS.0000000000000773","article-title":"Biliary adenofibroma of liver: morphology, tumor genetics, and outcomes in 6 cases","volume":"41","author":"Arnason","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2025.100815_bib16","first-page":"163","article-title":"Hepatic biliary adenofibroma: histological characteristics, diagnostic challenges, and its role as a precursor to intrahepatic cholangiocarcinoma","volume":"4","author":"Liao","year":"2024","journal-title":"J Clin Transl Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100815_bib17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12328-014-0523-1","article-title":"Biliary adenofibroma with ominous features of imminent malignant changes","volume":"7","author":"Tsutsui","year":"2014","journal-title":"Clin J Gastroenterol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100815_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s40792-019-0661-2","article-title":"A case of biliary adenofibroma of the liver with malignant transformation: a morphomolecular case report and review of the literature","volume":"5","author":"Sturm","year":"2019","journal-title":"Surg Case Rep"},{"issue":"1","key":"10.1016\/j.modpat.2025.100815_bib19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hep.28818","article-title":"Biliary adenofibroma: a rare hepatic lesion with malignant features","volume":"65","author":"Kaminsky","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.modpat.2025.100815_bib20","article-title":"Biliary adenofibroma: a rare liver tumor with transition to invasive carcinoma","volume":"2022","author":"Alshbib","year":"2022","journal-title":"Case Rep Surg"},{"issue":"5","key":"10.1016\/j.modpat.2025.100815_bib21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.prp.2015.12.015","article-title":"A case of biliary adenofibroma with malignant transformation","volume":"212","author":"Thai","year":"2016","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.modpat.2025.100815_bib22","doi-asserted-by":"crossref","DOI":"10.4322\/acr.2023.453","article-title":"Biliary adenofibroma: a precursor lesion of intrahepatic cholangiocarcinoma","volume":"13","author":"Parkhi","year":"2023","journal-title":"Autops Case Rep"},{"issue":"6","key":"10.1016\/j.modpat.2025.100815_bib23","doi-asserted-by":"crossref","first-page":"E107","DOI":"10.21037\/jgo.2016.09.14","article-title":"Malignant transformation of biliary adenofibroma: a rare biliary cystic tumor","volume":"7","author":"Thompson","year":"2016","journal-title":"J Gastrointest Oncol"},{"issue":"9","key":"10.1016\/j.modpat.2025.100815_bib24","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/PAS.0000000000002278","article-title":"Tubulocystic carcinoma of bile ducts: a distinct type of cholangiocarcinoma associated with adenofibroma-type lesions","volume":"48","author":"Masetto","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100815_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00428-024-03787-8","article-title":"Prognostic implications of tumor histology and microenvironment in surgically resected intrahepatic cholangiocarcinoma: a single institutional experience","volume":"486","author":"Chen","year":"2025","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.modpat.2025.100815_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24351","article-title":"Risk factors for cholangiocarcinoma","volume":"54","author":"Tyson","year":"2011","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.modpat.2025.100815_bib27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/his.14222","article-title":"Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma","volume":"78","author":"Sasaki","year":"2021","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.modpat.2025.100815_bib28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jcp-2024-209572","article-title":"von Meyenburg complexes are more frequently associated with cholangiocarcinoma","volume":"78","author":"Jain","year":"2025","journal-title":"J Clin Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100815_bib29","article-title":"Incidental biliary adenofibroma with dysplastic features","volume":"1","author":"Jacobs","year":"2015","journal-title":"BJR Case Rep"},{"issue":"1","key":"10.1016\/j.modpat.2025.100815_bib30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2214\/ajr.179.1.1790280","article-title":"Biliary adenofibroma with malignant transformation and pulmonary metastases: CT findings","volume":"179","author":"Akin","year":"2002","journal-title":"AJR Am J Roentgenol"},{"issue":"25","key":"10.1016\/j.modpat.2025.100815_bib31","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.12998\/wjcc.v10.i25.9104","article-title":"Malignant transformation of biliary adenofibroma combined with benign lymphadenopathy mimicking advanced liver carcinoma: a case report","volume":"10","author":"Wang","year":"2022","journal-title":"World J Clin Cases"},{"issue":"1","key":"10.1016\/j.modpat.2025.100815_bib32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13000-021-01142-y","article-title":"Congenital hepatic fibrosis and its mimics: a clinicopathologic study of 19 cases at a single institution","volume":"16","author":"Chen","year":"2021","journal-title":"Diagn Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2025.100815_bib33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41571-020-0357-3","article-title":"The SWI\/SNF complex in cancer - biology, biomarkers and therapy","volume":"17","author":"Mittal","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100815_bib34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4161\/cbt.28411","article-title":"The emerging roles of ARID1A in tumor suppression","volume":"15","author":"Wu","year":"2014","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"10.1016\/j.modpat.2025.100815_bib35","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/modpathol.2011.189","article-title":"Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations","volume":"25","author":"Yamamoto","year":"2012","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100815_bib36","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1038\/s41598-025-86384-2","article-title":"Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts","volume":"15","author":"Caumanns","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.modpat.2025.100815_bib37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13148-024-01805-9","article-title":"Impaired ARID1A expression attenuated the immune response in gastric cancer via histone acetylation","volume":"17","author":"Tang","year":"2025","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.modpat.2025.100815_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155763","article-title":"Molecular and pathological landscape of the AT-rich interaction domain 1A (ARID1A) mutation in hepatocellular carcinoma","volume":"266","author":"Li","year":"2025","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.modpat.2025.100815_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217506","article-title":"Integrative analysis of patient-derived tumoroids and ex vivo organoid modelling of ARID1A loss in bladder cancer reveals therapeutic molecular targets","volume":"614","author":"Scholtes","year":"2025","journal-title":"Cancer Lett"},{"key":"10.1016\/j.modpat.2025.100815_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155774","article-title":"Tumor infiltrating T-cells and loss of expression of SWI\/SNF genes in varying stages of clear cell renal cell carcinoma","volume":"266","author":"Hrizat","year":"2025","journal-title":"Pathol Res Pract"},{"issue":"11","key":"10.1016\/j.modpat.2025.100815_bib41","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1517\/14728222.2015.1062879","article-title":"Potential therapeutic targets in ARID1A-mutated cancers","volume":"19","author":"Bitler","year":"2015","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"10.1016\/j.modpat.2025.100815_bib42","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002491","article-title":"Loss of BAP1 expression occurs frequently in intrahepatic cholangiocarcinoma","volume":"95","author":"Andrici","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.modpat.2025.100815_bib43","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.modpat.2025.100815_bib44","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ng.2813","article-title":"Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas","volume":"45","author":"Jiao","year":"2013","journal-title":"Nat Genet"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225001115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225001115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:31:41Z","timestamp":1779780701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395225001115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0893395225001115"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100815","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of Cholangiocarcinomas With Tubulocystic Morphology Associated With Biliary Adenofibroma or Biliary Adenofibroma-Like Lesions","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100815"}}